934 related articles for article (PubMed ID: 26281945)
1. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
Johnson DA; Johnson JA
Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
[TBL] [Abstract][Full Text] [Related]
2. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
3. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
Denzer I; Münch G; Friedland K
Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
[TBL] [Abstract][Full Text] [Related]
4. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
[TBL] [Abstract][Full Text] [Related]
5. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
6. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
7. The role of Nrf2 signaling in counteracting neurodegenerative diseases.
Dinkova-Kostova AT; Kostov RV; Kazantsev AG
FEBS J; 2018 Oct; 285(19):3576-3590. PubMed ID: 29323772
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs.
Paladino S; Conte A; Caggiano R; Pierantoni GM; Faraonio R
Cell Physiol Biochem; 2018; 47(5):1951-1976. PubMed ID: 29969760
[TBL] [Abstract][Full Text] [Related]
9. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
11. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
van Muiswinkel FL; Kuiperij HB
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
[TBL] [Abstract][Full Text] [Related]
12. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
Cheng X; Ku CH; Siow RC
Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
[TBL] [Abstract][Full Text] [Related]
14. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.
Johnson JA; Johnson DA; Kraft AD; Calkins MJ; Jakel RJ; Vargas MR; Chen PC
Ann N Y Acad Sci; 2008 Dec; 1147():61-9. PubMed ID: 19076431
[TBL] [Abstract][Full Text] [Related]
15. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Buendia I; Michalska P; Navarro E; Gameiro I; Egea J; León R
Pharmacol Ther; 2016 Jan; 157():84-104. PubMed ID: 26617217
[TBL] [Abstract][Full Text] [Related]
16. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
Yang Y; Jiang S; Yan J; Li Y; Xin Z; Lin Y; Qu Y
Cytokine Growth Factor Rev; 2015 Feb; 26(1):47-57. PubMed ID: 25280871
[TBL] [Abstract][Full Text] [Related]
17. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases.
Singh S; Vrishni S; Singh BK; Rahman I; Kakkar P
Free Radic Res; 2010 Nov; 44(11):1267-88. PubMed ID: 20815789
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases.
Bai X; Bian Z; Zhang M
Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.
Lee DH; Gold R; Linker RA
Int J Mol Sci; 2012; 13(9):11783-11803. PubMed ID: 23109883
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
Xiang Y; Song X; Long D
Arch Toxicol; 2024 Mar; 98(3):579-615. PubMed ID: 38265475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
